Compare OTEX & ELAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OTEX | ELAN |
|---|---|---|
| Founded | 1991 | 1954 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.2B | 11.6B |
| IPO Year | 1998 | 2018 |
| Metric | OTEX | ELAN |
|---|---|---|
| Price | $22.96 | $22.95 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 10 | 9 |
| Target Price | ★ $37.50 | $27.63 |
| AVG Volume (30 Days) | 1.9M | ★ 3.9M |
| Earning Date | 05-05-2026 | 05-25-2026 |
| Dividend Yield | ★ 4.71% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 1.24 | N/A |
| Revenue | $2,815,241,000.00 | ★ $4,715,000,000.00 |
| Revenue This Year | $2.80 | $7.97 |
| Revenue Next Year | $1.05 | $5.21 |
| P/E Ratio | $18.81 | ★ N/A |
| Revenue Growth | ★ 22.88 | 6.22 |
| 52 Week Low | $22.44 | $8.02 |
| 52 Week High | $39.90 | $27.72 |
| Indicator | OTEX | ELAN |
|---|---|---|
| Relative Strength Index (RSI) | 33.75 | 37.91 |
| Support Level | $22.44 | $20.41 |
| Resistance Level | $33.67 | $23.70 |
| Average True Range (ATR) | 0.76 | 0.97 |
| MACD | 0.02 | -0.34 |
| Stochastic Oscillator | 1.37 | 8.68 |
Open Text Corp is engaged in the design, development, marketing, and sale of Information Management software and solutions. Its software allows clients to archive, aggregate, retrieve, and search unstructured information (such as documents, e-mail, and presentations). Its platform and services provide secure and scalable solutions for enterprises, SMBs, governments, and consumers around the world. The company's solutions are marketed and delivered on the OpenText Cloud Platform, which is a comprehensive Information Management platform consisting of six business clouds; Content Cloud, Cybersecurity Cloud, Application Automation Cloud, Business Network Cloud, IT Operations Management Cloud, and Analytics Cloud. Geographically, it derives maximum revenue from the United States.
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production.